Author

Sven Almer 1

1 Departm

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Fernando Gomollon Garcia, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James Lindsay, Laurent Peyrin-Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Geras

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish National Quality Registry for IBD, SWIBREG

Carl Eriksson, Isabella Visuri, Daniel Bergemalm, Sara Rundquist, Lina Vigren, Linda Nilsson, Anders Kärnell, Henrik Hjortswang, Ruzan Udumyan, Sven Almer, Erik Hertervig, Per Karlén, Hans Strid, Jonas Halfvarson

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl, Casper Steenholdt, Jens Frederik Dahlerup, Tobias Wirenfeldt Klausen, Mark Andrew Ainsworth, Jørgen Jahnsen, Jørn Brynskov, Ole Østergaard Thomsen, Katrine Risager Christensen, Akbar Molazahi, Natalia Pedersen, Niels Thorsgaard, Eva Efsen Dahl, Ida Vind, Hendrika Adriana Linda Kievit, Taina Sipponen, Jan Marsal;;

Effect of anti-TNF-α treatment in primary sclerosing cholangitis

Charlotte R H Hedin, Gina Sado, Ellina Lytvyak, Andrew L. Mason, Aldo Montano-Loza, Alessio J Gerussi, Douglas Thorburn, Emma Nilsson, Geir Larsson, Bjorn Moum, Kim N van Munster, Cyriel Y. Ponsioen, Cynthia Levy, Nicholas Nogueira, C L Bowlus, Neta Brender Gotlieb, Oren Shibolet, Kate D Lynch, Roger W Chapman, Christian

INCIDENCE AND DISEASE PRESENTATION OF ELDERLY-ONSET IBD IN A EUROPEAN POPULATION-BASED INCEPTION COHORT - AN ANALYSIS OF THE EPI-IBD 2010-2011 COHORTS

Vicent Hernández Ramírez, Jesus Martinez Cadilla, Shaji Sebastian, IOANNIS (JOHN) KAIMAKLIOTIS, Silvija Cukovic Cavka, Jens Frederik Dahlerup, Karin Ladefoged, Limas Kupcinskas, Svetlana Turcan, Natalia Pedersen, Ebbe Langholz, Niels Thorsgaard, Vibeke Andersen, Riina Salupere, Elena Belousova, Konstantinos H. Katsanos, Olg

INFLIXIMAB RESTORES THE BARRIER TO E. COLI IN ACTIVE CROHN’S COLITIS VIA EFFECTS ON LIPID RAFTS

Olena Yakymenko, Ida Schoultz, Elisabet Gullberg, Sven Almer, Magnus Strom, Åsa V. Keita, Conny Wallon, Barry J. Campbell, Derek M McKay, Johan D. Söderholm

LONG-TERM OUTCOME IN PATIENTS WITH CHRONIC ACTIVE ULCERATIVE COLITIS STARTED ON INFLIXIMAB: A RETROSPECTIVE SWEDISH MULTICENTER STUDY

Leif Angelison, Sven Almer, Antal Bajor, Jan Björk, Michael Eberhardsson, Anders Eriksson, Olof Grip, Per Hammarlund, Ulf Hindorf, Pontus Karling, Mari Thörn, Jörgen Torp, Erik Hertervig

MICROSCOPIC COLITIS NO MORE: HLA ASSOCIATION DISCRIMINATES COLLAGENOUS FROM LYMPHOCYTIC COLITIS

Tenghao Zheng, Giulia Roda, Yamile Zabana, Xingrong Liu, Ye Chen, Leticia Camargo-Tavares, Bodil Ohlsson, Wolfgang Lieb, Maria Esteve Comas, Antonio Julià, Sara Marsal, Rinse K. Weersma, Luis Bujanda Fernández de Piérola, Marie-Rose Mellander, Francesca Bresso, Jonas Halfvarson, Juozas Kupcinskas, Inga Peter, Andre Franke

THE OCCURENCE OF ANAEMIA AND ANAEMIA SUBTYPES DURING THE FIRST YEAR OF DISEASE IN AN EAST-WEST EUROPEAN INCEPTION COHORT ? AN ECCO-EPICOM COHORT STUDY

Johan Burisch, Lars Ulrik Gerdes, Sven Almer, S. Cukovic Cavka, Shaji Sebastian, IOANNIS (JOHN) KAIMAKLIOTIS, Dana Duricova, Natalia Pedersen, Riina Salupere, Kari Rubek Nielsen, Pia Maria Oksanen, Konstantinos H. Katsanos, Shmuel Odes, Vibeke Andersen, Daniela Valpiani, Limas Kupcinskas, Svetlana Turcan, Fernando Jose Mag

Item 1 - 9 / 15
1
2